Cargando…

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives

The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW‐ADNI) is a collaborative effort to investigate imaging and biofluid markers that can inform Alzheimer's disease treatment trials. It is a public‐private partnership that spans North America, Argentina, Australia, Canada, China,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Christopher J., Carrillo, Maria C., Jagust, William, Jack, Clifford R., Shaw, Leslie M., Trojanowski, John Q., Saykin, Andrew J., Beckett, Laurel A., Sur, Cyrille, Rao, Naren P., Mendez, Patricio Chrem, Black, Sandra E., Li, Kuncheng, Iwatsubo, Takeshi, Chang, Chiung‐Chih, Sosa, Ana Luisa, Rowe, Christopher C., Perrin, Richard J., Morris, John C., Healan, Amanda M.B., Hall, Stephen E., Weiner, Michael W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719344/ https://www.ncbi.nlm.nih.gov/pubmed/35005206 http://dx.doi.org/10.1002/trc2.12226

Ejemplares similares

Imago Mundi, Imago AD, Imago ADNI
por: Villemagne, Victor L, et al.
Publicado: (2014)

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
por: Toledo, Jon B, et al.
Publicado: (2014)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2
por: Edgar, Chris J., et al.
Publicado: (2021)

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
por: Veitch, Dallas P., et al.
Publicado: (2021)

Development and validation of language and visuospatial composite scores in ADNI
por: Choi, Seo‐Eun, et al.
Publicado: (2020)

β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3
por: Bourgeat, Pierrick, et al.
Publicado: (2022)

Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
por: Toledo, Jon B., et al.
Publicado: (2013)

Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging
por: Fujishima, Motonobu, et al.
Publicado: (2017)

Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI
por: Shishegar, Rosita, et al.
Publicado: (2021)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
por: Brunton, Simon, et al.
Publicado: (2015)

Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
por: Vasanthakumar, Aparna, et al.
Publicado: (2020)

Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4
por: Weiner, Michael W., et al.
Publicado: (2022)

Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer’s disease: a study of ADNI cohorts
por: Song, Ailin, et al.
Publicado: (2016)

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019)

Evaluation of PiB visual interpretation with CSF Aβ and longitudinal SUVR in J-ADNI study
por: Okada, Yusuke, et al.
Publicado: (2019)

How Will Aducanumab Approval Impact AD Research?
por: Weiner, Michael W., et al.
Publicado: (2021)

Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers
por: Tosun, Duygu, et al.
Publicado: (2021)

Identifying progressive imaging genetic patterns via multi-task sparse canonical correlation analysis: a longitudinal study of the ADNI cohort
por: Du, Lei, et al.
Publicado: (2019)

Systematic comparison of different techniques to measure hippocampal subfield volumes in ADNI2
por: Mueller, Susanne G., et al.
Publicado: (2017)

Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
por: Huckvale, Erik D., et al.
Publicado: (2021)

Cognitive dedifferentiation as a function of cognitive impairment in the ADNI and MemClin cohorts
por: Wallert, John, et al.
Publicado: (2021)

MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials
por: Hua, Xue, et al.
Publicado: (2015)

Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort
por: Li, Jin, et al.
Publicado: (2015)

Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort
por: Cong, Wang, et al.
Publicado: (2017)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
por: Gamberger, Dragan, et al.
Publicado: (2016)

Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI
por: Windon, Charles, et al.
Publicado: (2022)

Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer’s disease in veterans, using the Alzheimer’s Disease Neuroimaging Initiative
por: Weiner, Michael W., et al.
Publicado: (2014)

Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort
por: Zainul Abidin, Fatin N., et al.
Publicado: (2021)

CSF biomarkers of Alzheimer’s disease concord with amyloid-β PETand predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
por: Hansson, Oskar, et al.
Publicado: (2018)

Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study
por: Li, Bolun, et al.
Publicado: (2016)

Mapping the Genetic Variation of Regional Brain Volumes as Explained by All Common SNPs from the ADNI Study
por: Bryant, Christopher, et al.
Publicado: (2013)

Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2019)

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013)

Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI
por: Ding, Xiuhua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d43st4qgsgsctejq679vjuqf70